Breadcrumb

Breadcrumbs

Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Wed Aug 24 00:00:00 GMT-04:00 2016
Data from Phase 3b ENSURE-AF Study Investigating Once-Daily SAVAYSA® (edoxaban) in Patients with At ...
PDF (328 KB)
Thu Aug 18 00:00:00 GMT-04:00 2016
Daiichi Sankyo, Inc. Adds to Its Dynamic Team, Welcoming Leigh Ann Errico as the New Vice President ...
PDF (230 KB)
Mon Jun 13 00:00:00 GMT-04:00 2016
Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Announce FDA Acceptance of New Drug Applicat ...
PDF (423 KB)
Tue May 31 00:00:00 GMT-04:00 2016
Daiichi Sankyo Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer (NSCL ...
PDF (124 KB)
Mon Apr 18 00:00:00 GMT-04:00 2016
Daiichi Sankyo, Inc. To Establish New U.S. Headquarters in Basking Ridge, New Jersey
PDF (87 KB)
Fri Apr 01 00:00:00 GMT-04:00 2016
Daiichi Sankyo Announces Appointment of Antoine Yver, MD, MSc to Global Head, Oncology Research and ...
PDF (146 KB)
Mon Mar 28 00:00:00 GMT-04:00 2016
New 2016 ACC/AHA Guideline Focused Update States that it is Reasonable to Choose Effient® (prasugre ...
PDF (179 KB)
Thu Mar 24 00:00:00 GMT-04:00 2016
Daiichi Sankyo to Present Findings From New Subgroup Analyses of Once-Daily SAVAYSA® (edoxaban) in ...
PDF (405 KB)
Tue Mar 22 00:00:00 GMT-04:00 2016
DAIICHI SANKYO AND ARQULE ANNOUNCE CONTINUATION OF METIV-HCC PHASE 3 STUDY OF TIVANTINIB IN SECOND- ...
PDF (238 KB)
Showing 21 - 29 of 29 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...